Involvement of hyaluronan in epidermal Langerhans cell maturation and migration in vivo

Journal of Dermatological Science

Volumn 33, Issue 2, 2003, Pages 91-97

  Mummert, Diana I ^a   Takashima, Akira ^a   Ellinger, Lesa ^a   Mummert, Mark E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Hyaluronan; Langerhans cells; Maturation; Migration

Indexed keywords

CD86 ANTIGEN; GLYCYLALANYLHISTIDYLTRYPTOPHYLGLUTAMINYLPHENYLALANYLASPARAGINYLALANYLLEUCYL THREONYLVALYLARGININE; HAPTEN; HYALURONIC ACID; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL DENSITY; CELL KINETICS; CELL MATURATION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; IMMUNOSTIMULATION; IN VIVO STUDY; LANGERHANS CELL; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0142168897     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(03)00160-9     Document Type: Article

References (44)

1. Streilein J.W., Toews G.T., Gilliam J.N., Bergstresser P.R. Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis. J. Invest. Dermatol. 74:1980;319-322.
2. Streilein J.W., Bergstresser P.R. Langerhans cell function dictates induction of contact hypersensitivity or unresponsiveness to DNFB in Syrian hamsters. J. Invest. Dermatol. 77:1981;272-277.
3. Pehamberger H., Stingl L.A., Pogantsch S., Steiner G., Wolff K., Stingl G. Epidermal cell-induced generation of cytotoxic T-lymphocyte responses against alloantigens or TNP-modified syngeneic cells: requirement for Ia-positive Langerhans cells. J. Invest. Dermatol. 81:1983;208-211.
4. Hauser C., Katz S.I. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proc. Natl. Acad. Sci. USA. 85:1988;5625-5628.
5. Hauser C., Yokoyama W.M., Katz S.I. Characterization of primary T helper cell activation and T helper cell lines stimulated by hapten-modified, cultured Langerhans cells. J. Invest. Dermatol. 93:1989;649-655.
6. Kolde G. Effects of immunological responsiveness on Langerhans cell behavior in contact sensitization. Exp. Dermatol. 3:1994;269-275.
7. Antonopoulos C., Cumberbatch M., Dearman R.J., Daniel R.J., Kimber I., Groves R.W. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166:2001;3672-3677.
8. Wang B., Amerio P., Sauder D.N. Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol. 66:1999;33-39.
9. Cumberbatch M., Dearman R.J., Griffiths C.E., Kimber I. Langerhans cell migration. Clin. Exp. Dermatol. 25:2000;413-418.
10. Kimber I., Cumberbatch M., Dearman R.J., Bhushan M., Griffiths C.E. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization. Br. J. Dermatol. 142:2000;401-412.
11. Enk A.H., Angeloni V.L., Udey M.C., Katz S.I. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J. Immunol. 150:1993;3698-3704.
12. Knop J., Enk A.H. Cellular and molecular mechanisms in the induction phase of contact sensitivity. Int. Arch. Allergy Immunol. 107:1995;231-232.
13. Cumberbatch M., Dearman R.J., Kimber I. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology. 92:1997;388-395.
14. Wang B., Fujisawa H., Zhuang L., Kondo S., Shivji G.M., Kim C.S., et al. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J. Immunol. 159:1997;6148-6155.
15. Cumberbatch M., Dearman R.J., Kimber I. Langerhans cell migration in mice requires intact type I interleukin 1 receptor (IL-1RI) function. Arch. Dermatol. Res. 291:1999;357-361.
16. Wang B., Zhuang L., Fujisawa H., Shinder G.A., Feliciani C., Shivji G.M., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162:1999;277-283.
17. Tang A., Amagai M., Granger L.G., Stanley J.R., Udey M.C. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature. 361:1993;82-85.
18. 6 integrins are required for Langerhans cell migration from the epidermis. J. Exp. Med. 186:1997;1725-1735.
19. Osada A., Nakashima H., Furue M., Tamaki K. Up regulation of CD44 expression by tumor necrosis factor-α is neutralized by interleukin-10 in Langerhans cells. J. Invest. Dermatol. 105:1995;124-127.
20. Weiss J.M., Sleeman J., Renkl A.C., Dittmar H., Termeer C.C., Taxis S., et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J. Cell Biol. 137:1997;1137-1147.
21. Ma J., Wang J.H., Guo Y.J., Sy M.S., Bigby M. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol. 158:1994;389-399.
22. Xu H., Guan H., Zu G., Bullard D., Hanson J., Slater M., et al. The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur. J. Immunol. 31:2001;3085-3093.
23. Kobayashi Y., Matsumoto M., Kotani M., Makino T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163:1999;5989-5993.
24. Ratzinger G., Stoitzner P., Ebner S., Lutz M.B., Layton G.T., Rainer C., et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168:2002;4361-4371.
25. Noirey N., Staquet M.J., Gariazzo M.J., Serres M., Andre C., Schmitt D., et al. Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells. Eur. J. Cell Biol. 81:2002;383-389.
26. Saeki H., Moore A.M., Brown M.J., Hwang S.T. Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 162:1999;2472-2475.
27. Randolph G.J. Is maturation required for Langerhans cell migration? J. Exp. Med. 196:2002;413-416.
28. Jolles S., Christensen J., Holman M., Klaus G.B., Ager A. Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin. Clin. Exp. Immunol. 129:2002;519-526.
29. Kurz S.M., Diebold S.S., Hieronymus T., Gust T.C., Bartunek P., Sachs M., et al. The impact of c-met/scatter factor receptor on dendritic cell migration. Eur. J. Immunol. 32:2002;1832-1838.
30. Geissmann F., Dieu-Nosjean M.C., Dezutter C., Valladeau J., Kayal S., Leborgne M., et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J. Exp. Med. 196:2002;417-430.
31. Angeli V., Faveeuw C., Roye O., Fontaine J., Teissier E., Capron A., et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J. Exp. Med. 193:2001;1135-1147.
32. Mummert M.E., Mohamadzadeh M., Mummert D.I., Mizumoto N., Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J. Exp. Med. 192:2000;769-779.
33. Termeer C.C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., et al. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165:2000;1863-1870.
34. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., et al. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:2002;99-111.
35. Abeyama K., Eng W., Jester J.V., Vink A.A., Edelbaum D., Cockerell C.J., et al. A role for NF-κB-dependent gene transactivation in sunburn. J. Clin. Invest. 105:2000;1751-1759.
36. Suzuki H., Wang B., Shivji G.M., Toto P., Amerio P., Tomai M.A., et al. Imiquimod a topical immune response modifier, induces migration of Langerhans cells. J. Invest. Dermatol. 114:2000;135-141.
37. Rattis F.M., Peguet-Navarro J., Staquet M.J., Dezutter-Dambuyant C., Courtellemont P., Redziniak G., et al. Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur. J. Immunol. 26:1996;449-453.
38. Nuriya S., Yagita H., Okumura K., Azuma M. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int. Immunol. 8:1996;917-926.
39. Péguet-Navarro J., Dalbiez-Gauthier C., Dezutter-Dambuyant C., Schmitt D. Dissection of human Langerhans cells' allostimulatory function: the need for an activation step for full development of accessory function. Eur. J. Immunol. 23:1993;376-382.
40. Aiba S., Katz S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J. Immunol. 145:1990;2791-2796.
41. O'Sullivan G.M., Boswell C.M., Halliday G.M. Langerhans cell migration is modulated by N-sulfated glucosamine moieties in heparin. Exp. Dermatol. 9:2000;25-33.
42. Culty M., Nguyen H.A., Underhill C.B. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J. Cell Biol. 116:1992;1055-1062.
43. Camp R.D., Scheynius A., Johansson C., Puré E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:1993;497-507.
44. Sleeman J., Rudy W., Hofmann M., Moll J., Herrlich P., Ponta H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell Biol. 135:1996;1139-1150.